Evidence map›Paper›PMID 20926762›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2010

Effect of intracerebroventricular benzamil on cardiovascular and central autonomic responses to DOCA-salt treatment.

Joanna M Abrams, William C Engeland, John W Osborn

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. DOCA-salt hypertension and the role of the OVLT-sympathetic-gut microbiome axis.Clinical and experimental pharmacology & physiology · 2021
    Article
  5. Article
  6. Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats.American journal of physiology. Regulatory, integrative and comparative physiology · 2018
    Article
  7. Article
  8. Article
  9. DOCA-Salt Hypertension: an Update.Current hypertension reports · 2017
    Review
  10. Review
  11. The multifaceted mineralocorticoid receptor.Comprehensive Physiology · 2014
    Review
  12. Article
  13. Review
  14. ENaC-expressing neurons in the sensory circumventricular organs become c-Fos activated following systemic sodium changes.American journal of physiology. Regulatory, integrative and comparative physiology · 2013
    Article
  15. Effects of intrathecal kynurenate on arterial pressure during chronic osmotic stress in conscious rats.American journal of physiology. Heart and circulatory physiology · 2013
    Article
  16. Central neuromodulatory pathways regulating sympathetic activity in hypertension.Journal of applied physiology (Bethesda, Md. : 1985) · 2012
    Review
  17. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.American journal of physiology. Heart and circulatory physiology · 2012
    Review
  18. Article
  19. Article
  20. Role of spinal V1a receptors in regulation of arterial pressure during acute and chronic osmotic stress.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Joanna M AbramsDepartment of Neuroscience, University of Minnesota, Minneapolis, Minnesota, USA.
William C Engeland
John W Osborn
University of Minnesota · US

Funding

Long-Term Neural Determinants of Cardiovascular DiseasesR01HL076312 · NHLBI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI OSBORN, JOHN W · 2005 to 2009
$5.6M
NHLBI NIH HHS R01 HL076312NHLBI NIH HHS R01-HL-64176
6 · The paper itself

Abstract

DOCA-salt treatment increases mean arterial pressure (MAP), while central infusion of benzamil attenuates this effect. The present study used c-Fos immunoreactivity to assess the role of benzamil-sensitive proteins in the brain on neural activity following chronic DOCA-salt treatment. Uninephrectomized rats were instrumented with telemetry transmitters for measurement of MAP and with an intracerebroventricular (ICV) cannula for benzamil administration. Groups included rats receiving DOCA-salt treatment alone, rats receiving DOCA-salt treatment with ICV benzamil, and appropriate controls. At study completion, MAP in vehicle-treated DOCA-salt rats reached 142 ± 4 mmHg. In contrast DOCA-salt rats receiving ICV benzamil had lower MAP (124 ± 3 mmHg). MAP in normotensive controls was 102 ± 3 mmHg. c-Fos immunoreactivity was quantified in the supraoptic nucleus (SON) and across subnuclei of the hypothalamic paraventricular nucleus (PVN), as well as other cardiovascular regulatory sites. Compared with vehicle-treated normotensive controls, c-Fos expression was increased in the SON and all subnuclei of the PVN, but not in other key autonomic nuclei, such as the rostroventrolateral medulla. Moreover, benzamil treatment decreased c-Fos immunoreactivity in the SON and in medial parvocellular and posterior magnocellular neurons of the PVN in DOCA-salt rats but not areas associated with regulation of sympathetic activity. Our results do not support the hypothesis that DOCA-salt increases neuronal activity (as indicated by c-Fos immunoreactivity) of other key regions that regulate sympathetic activity. These results suggest that ICV benzamil attenuates DOCA-salt hypertension by modulation of neuroendocrine-related PVN nuclei rather than inhibition of PVN sympathetic premotor neurons in the PVN and rostroventrolateral medulla.

Indexed as

AmilorideAnalysis of VarianceAnimalsAutonomic Nervous SystemBlood PressureBrainCell CountDesoxycorticosteroneImmunohistochemistryInjections, IntraventricularMaleMineralocorticoidsNeuronsProto-Oncogene Proteins c-fosRatsRats, Sprague-DawleyAmiloridebenzamilDesoxycorticosteroneMineralocorticoidsProto-Oncogene Proteins c-fos

Identifiers

PMID20926762
PMCPMC3007181
OpenAlexW2050665701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.